Natural history of cerebral vein thrombosis: A systematic review

Blood

Volumn 108, Issue 4, 2006, Pages 1129-1134

  Dentali, Francesco ^b   Gianni, Monica ^b   Crowther, Mark A ^a   Ageno, Walter ^b  

^a ST JOSEPH S HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

BRAIN VEIN; CLINICAL TRIAL; COGNITIVE DEFECT; DISABILITY; FOLLOW UP; HOSPITALIZATION; HUMAN; LONG TERM CARE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RECANALIZATION; RECURRENT DISEASE; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; VEIN THROMBOSIS;

EID: 33747180820     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-12-4795     Document Type: Review

References (36)

1. Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F. ISCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004;35:664-670.
2. Ameri A, Bousser MG. Cerebral venous thrombosis. Neurol Clin. 1992;10:87-111.
3. Gates PC. Cerebral venous thrombosis: a retrospective review. Aust N Z J Med. 1986;16:766-770.
4. de Bruijn SF, de Haan RJ, Stam J. Clinical features and prognostic factors of cerebral venous sinus thrombosis in a prospective series of 59 patients: for The Cerebral Venous Sinus Thrombosis Study Group. J Neurol Neurosurg Psychiatry. 2001;70:105-108.
5. Barnett HJ, Hyland HH. Noninfective intracranial venous thrombosis. Brain. 1953;76:36-49.
6. Ferro JM, Correia M, Pontes C, Baptista MV, Pita F. Cerebral Venous Thrombosis Portuguese Collaborative Study Group (Venoport). Cerebral vein and dural sinus thrombosis in Portugal, 1980-1998. Cerebrovasc Dis. 2001;11:177-182.
7. Daif A, Awada A, al-Rajeh S, et al. Cerebral venous thrombosis in adults: a study of 40 cases from Saudi Arabia. Stroke. 1995;26:1193-1195.
8. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008-2012.
9. Stolz E, Rahimi A, Gerriets T, Kraus J, Kaps M. Cerebral venous thrombosis: an all or nothing disease? Prognostic factors and long-term outcome. Clin Neurol Neurosurg. 2005;107:99-107.
10. Stolz E, Trittmacher S, Rahimi A, et al. Influence of recanalization on outcome in dural sinus thrombosis: a prospective study. Stroke. 2004;35:544-547.
11. Favrole P, Guichard JP, Crassard I, Bousser MG, Chabriat H. Diffusion-weighted imaging of intravascular clots in cerebral venous thrombosis. Stroke. 2004;35:99-103.
12. Baumgartner RW, Studer A, Arnold M, Georgiadis D. Recanalisation of cerebral venous thrombosis. J Neurol Neurosurg Psychiatry. 2003;74:459-461.
13. Buccino G, Scoditti U, Patteri I, Bertolino C, Mancia D. Neurological and cognitive long-term outcome in patients with cerebral venous sinus thrombosis. Acta Neurol Scand. 2003;107:330-335.
14. Cakmak S, Derex L, Berruyer M, et al. Cerebral venous thrombosis: clinical outcome and systematic screening of prothrombotic factors. Neurology. 2003;60:1175-1178.
15. Mehraein S, Ortwein H, Busch M, Weih M, Einhaupl K, Masuhr F. Risk of recurrence of cerebral venous and sinus thrombosis during subsequent pregnancy and puerperium. J Neurol Neurosurg Psychiatry. 2003;74:814-816.
16. Ferro JM, Lopes MG, Rosas MJ, Ferro MA, Fontes J. Cerebral Venous Thrombosis Portuguese Collaborative Study Group. Long-term prognosis of cerebral vein and dural sinus thrombosis: results of the VENOPORT study. Cerebrovasc Dis. 2002;13:272-278.
17. Strupp M, Covi M, Seelos K, Dichgans M, Brandt T. Cerebral venous thrombosis: correlation between recanalization and clinical outcome: a long-term follow-up of 40 patients. J Neurol. 2002;249:1123-1124.
18. Fink JN, McAuley DL. Cerebral venous sinus thrombosis: a diagnostic challenge. Intern Med J. 2001;31:384-390.
19. de Bruijn SF, Budde M, Teunisse S, de Haan RJ, Stam J. Long-term outcome of cognition and functional health after cerebral venous sinus thrombosis. Neurology. 2000;54:1687-1689.
20. Mak W, Mok KY, Tsoi TH, Cheung RT, Ho SL, Chang CM. Cerebral venous thrombosis in Hong Kong. Cerebrovasc Dis. 2001;11:282-283.
21. Breteau G, Mounier-Vehier F, Godefroy O, et al. Cerebral venous thrombosis 3-year clinical outcome in 55 consecutive patients. J Neurol. 2003;250:29-35.
22. Lamy C, Hamon JB, Coste J, Mas JL. Ischemic stroke in young women: risk of recurrence during subsequent pregnancies. French Study Group on Stroke in Pregnancy. Neurology. 2000;55:269-274.
23. Lleo A, Marti-Fabregas J, Guardia E, Marti-Vilalta JL. Cerebral venous thrombosis: study of 17 cases. Med Clin (Barc). 1999;113:537-540.
24. Preter M, Tzourio C, Ameri A, Bousser MG. Long-term prognosis in cerebral venous thrombosis: follow-up of 77 patients. Stroke. 1996;27:243-246.
25. Rondepierre P, Hamon M, Leys D, et al. Cerebral venous thromboses: study of the course. Rev Neurol (Paris). 1995;151:100-104.
26. Bienfait HP, Stam J, Lensing AW, van Hilten JJ. Thrombosis of the cerebral veins and sinuses in 62 patients. Ned Tijdschr Geneeskd. 1995;139:1286-1291.
27. Canhao P, Ferro JM, Lindgren AG, Bousser MG, Stam J, Barinagarrementeria F. ISCVT Investigators. Causes and predictors of death in cerebral venous thrombosis. Stroke. 2005;36:1720-1725.
28. Appenzeller S, Zeller CB, Annichino-Bizzachi JM, et al. Cerebral venous thrombosis: influence of risk factors and imaging findings on prognosis. Clin Neurol Neurosurg. 2005;107:371-378.
29. Davis HF, Croft JB, Malarcher AM, et al. Public Health and Aging: hospitalization foe stroke among adults aged ≥ 65 years - United States, 2000. JAMA. 2003;290:1023-1024.
30. Bravata DM, Ho SY, Brass LM, Concato J, Scinto J, Meehan TP. Long-term mortality in cerebrovascular disease. Stroke. 2003;34:699-704.
31. Hendricks HT, van Limbeek J, Geurts AC, Zwarts MJ. Motor recovery after stroke: a systematic review of the literature. Arch Phys Med Rehabil. 2002;83:1629-1637.
32. Lai SM, Studenski S, Duncan PW, Perera S. Persisting consequences of stroke measured by the Stroke Impact Scale. Stroke. 2002;33:1840-1844.
33. Hardie K, Hankey GJ, Jamrozik K, Broadhurst RJ, Anderson C. Ten-year risk of first recurrent stroke and disability after first-ever stroke in the Perth Community Stroke Study. Stroke. 2004;35:731-735.
34. Dentali F, Crowther M, Ageno W. Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis. Blood. 2006;107:2766-2773.
35. de Bruijn SF, Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke. 1999;30:484-488.
36. Einhaupl KM, Villringer A, Meister W, et al. Heparin treatment in sinus venous thrombosis. Lancet. 1991;338:597-600.